#drugresponse
#OMEZarr is here, what are the tools that make it usable in practice?
Great talk by Virginie Uhlmann on FRACTAL, showing OME-Zarr workflows with real-world image analysis applications like #drugresponse
fractal-analytics-platform.github.io
#ELMI2026
@royalmicrosoc.bsky.social
Fractal Analytics Platform
fractal-analytics-platform.github.io
June 17, 2026 at 3:52 PM
The Specification Game: Rethinking the Evaluation of DrugResponse Prediction for Precision Oncology https://www.biorxiv.org/content/10.1101/2024.10.01.616046v1
The Specification Game: Rethinking the Evaluation of DrugResponse Prediction for Precision Oncology https://www.biorxiv.org/content/10.1101/2024.10.01.616046v1
Precision oncology plays a pivotal role in contemporary healthcare, aiming to optimize treatments fo
www.biorxiv.org
October 3, 2024 at 3:47 PM
CJPP now features clinical pharmacology studies that account for differences in drug response across gender, physiology, and broader social determinants of health. Learn more ▶️ https://ow.ly/7AfT50XwTub

#DrugResponse #HealthEquity
January 9, 2026 at 2:35 PM
The Specification Game: Rethinking the Evaluation of DrugResponse Prediction for Precision Oncology https://www.biorxiv.org/content/10.1101/2024.10.01.616046v1
The Specification Game: Rethinking the Evaluation of DrugResponse Prediction for Precision Oncology https://www.biorxiv.org/content/10.1101/2024.10.01.616046v1
Precision oncology plays a pivotal role in contemporary healthcare, aiming to optimize treatments fo
www.biorxiv.org
October 3, 2024 at 3:47 PM
At this week’s #JEMS, Michael Zimmermann (@zimmermannlab.bsky.social & @embl.org) shared insights on how gut microbiota shape #drugmetabolism and carcinogen toxicity. Fascinating findings on cancer risk, #drugresponse variability, and limits of current models. Thanks for the inspiring talk!
September 10, 2025 at 11:57 AM